Wednesday, December 31, 2025 | 07:50 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Oxygenta Pharmaceutical Ltd / Announcements / BSE

Oxygenta Pharmaceutical Ltd

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

04:25 PM, 17th Dec 2025

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd

More Oxygenta Pharmaceutical Ltd Announcements

    View more
    Business Standard
    HOT STOCKS
    TOP SECTIONS
    KEY EVENTS
    Copyrights © 2025 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon